HIGH-RISK CANCER
Clinical trials for HIGH-RISK CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to wipe out prostate tumors before surgery
Disease control OngoingThis phase 2 trial is testing whether giving the targeted drug olaparib (Lynparza) along with hormone therapy for 6 months before surgery can shrink or eliminate prostate cancer in men with high-risk disease and specific gene mutations. About 32 men will receive the treatment, th…
Matched conditions: HIGH-RISK CANCER
Phase: PHASE2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Patients choose: transplant or Non-Transplant for rare bone marrow cancer?
Disease control OngoingThis study looks at two treatment options for people with a high-risk form of myelofibrosis, a rare bone marrow cancer. Participants choose whether they want a stem cell transplant or the best non-transplant treatments available. Researchers then track survival and quality of lif…
Matched conditions: HIGH-RISK CANCER
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Radiation before chemo: a new strategy to fight High-Risk breast cancer?
Disease control OngoingThis trial is testing whether giving a small dose of targeted radiation to a part of the breast tumor before standard chemotherapy can help the immune system fight the cancer more effectively. The study includes 40 people with high-risk or locally advanced breast cancer. After ra…
Matched conditions: HIGH-RISK CANCER
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Will High-Risk smokers keep up with lung scans? french study aims to find out
Knowledge-focused OngoingThis study tracks 126 heavy smokers aged 50 to 74 in France to see how many complete a three-year lung cancer screening program using low-dose CT scans. Researchers also measure how many people quit smoking during the program. The goal is to understand real-world adherence, not t…
Matched conditions: HIGH-RISK CANCER
Phase: NA • Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC